Health-related quality of life in relapsing remitting multiple sclerosis (RRMS) patients treated with placebo or BG-12 (dimethyl fumarate): comparison with other medical conditions

被引：0
|
作者：
Sarda, S.
Phillips, G.
Gaebler, J. A.
Kurukulasuriya, N. C.
机构：
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [21] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study
    Bar-Or, Amit
    Gold, Ralf
    Kappos, Ludwig
    Arnold, Douglas L.
    Giovannoni, Gavin
    Selmaj, Krzysztof
    O'Gorman, John
    Stephan, Monica
    Dawson, Katherine T.
    JOURNAL OF NEUROLOGY, 2013, 260 (09) : 2297 - 2305
  • [22] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study
    Hutchinson, Michael
    Fox, Robert J.
    Miller, David H.
    Phillips, J. Theodore
    Kita, Mariko
    Havrdova, Eva
    O'Gorman, John
    Zhang, Ray
    Novas, Mark
    Viglietta, Vissia
    Dawson, Katherine T.
    JOURNAL OF NEUROLOGY, 2013, 260 (09) : 2286 - 2296
  • [23] Efficacy and Safety of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis in the Phase 3 CONFIRM Study
    Hutchinson, M.
    Fox, R. J.
    Phillips, J. T.
    Miller, D. H.
    Havrdova, E.
    Kita, M.
    Yang, M.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 683 - 683
  • [24] Effect of BG-12 (dimethyl fumarate) in newly diagnosed patients with relapsing-remitting multiple sclerosis from the DEFINE and CONFIRM studies
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    JOURNAL OF NEUROLOGY, 2013, 260 : S51 - S51
  • [25] Immunophenotyping of Depression and Fatigue in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Dimethyl Fumarate
    Lee, Chieh-Hsin
    Zaeem, Zoya
    Barilla, David
    Nakhaei-Nejad, Maryam
    Giuliani, Fabrizio
    NEUROLOGY, 2019, 92 (15)
  • [26] CLINICAL AND NEURORADIOLOGICAL EFFECT OF BG-12 (DIMETHYL FUMARATE) IN SUBGROUPS OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS): AN INTEGRATED ANALYSIS OF THE PHASE 3 DEFINE AND CONFIRM STUDIES
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Miller, D. H.
    Arnold, D. L.
    O'Gorman, J.
    Yang, M.
    Sheikh, S., I
    Viglietta, V.
    Dawson, K. T.
    Hutchinson, M.
    VALUE IN HEALTH, 2013, 16 (03) : A102 - A102
  • [27] Clinical and Neuroradiologic Efficacy of BG-12 (Dimethyl Fumarate) in US Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Kita, Mariko
    Fox, Robert
    Phillips, J. Theodore
    Arnold, Douglas
    Bar-Or, Amit
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine
    Viglietta, Vissia
    Sheikh, Sarah
    Gold, Ralf
    NEUROLOGY, 2013, 80
  • [28] Safety and Tolerability of BG-12 in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Analyses From the CONFIRM Study
    Phillips, J. Theodore
    Fox, Robert
    Miller, David
    Kita, Mariko
    Hutchinson, Michael
    Havrdova, Eva
    Raghupathi, Kartik
    Yuan, Huixing
    Novas, Mark
    Viglietta, Vissia
    Dawson, Katherine
    NEUROLOGY, 2012, 78
  • [29] Systematic Literature Review and Mixed Treatments Comparison of BG-12 (Dimethyl Fumarate) and Disease Modifying Therapies for Relapsing-Remitting Multiple Sclerosis
    Hutchinson, Michael
    Fox, Robert
    Havrdova, Eva
    Deniz, Baris
    Sarda, Sujata
    Jindal, Ramandeep
    Kapoor, Anuj
    NEUROLOGY, 2013, 80
  • [30] Effects of BG-12 on quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study
    Kita, M.
    Fox, R. J.
    Phillips, J. T.
    Hutchinson, M.
    Havrdova, E.
    Sarda, S. P.
    Kong, J.
    Viglietta, V.
    Sheikh, S. I.
    Dawson, K. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 254 - 254
12345